OmniAb, Inc. (OABI) - Dilution Analysis

10-Q filing | 145.0M shares outstanding

10-Q filing | 144.0M shares outstanding

S-3 filing: This is an S-3 filing for the resale of 21,254,106 shares of common stock by selling stockholders, originally issued in a private placement on August 26, 2025.

10-Q filing | 122.7M shares outstanding

10-Q filing | 122.3M shares outstanding

10-K filing | 122.1M shares outstanding

10-Q filing | 121.0M shares outstanding

10-Q filing | 118.2M shares outstanding

10-Q filing | 117.6M shares outstanding

10-K filing | 117.1M shares outstanding

S-3 filing: The company is filing an S-3 to offer and sell up to $300 million in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings.

POS AM filing: This is a POS AM filing for OmniAb, Inc. registering up to 36,304,385 shares of common stock, up to 11,345,489 warrants, and up to 19,012,156 shares of common stock issuable upon exercise of warrants for resale by selling securityholders and issuance by the company.

10-Q filing | 116.2M shares outstanding

10-Q filing | 116.2M shares outstanding

10-Q filing | 115.6M shares outstanding

POS AM filing: This is a POS AM filing by OmniAb, Inc. registering for resale shares of common stock and warrants held by selling securityholders, as well as registering shares of common stock issuable upon exercise of warrants and options.

10-K filing | 115.6M shares outstanding

S-1/A filing: This S-1/A filing relates to the issuance by OmniAb, Inc. of up to 24,273,938 shares of common stock, and the offer and resale from time to time by the selling securityholders of up to 36,450,645 shares of Common Stock and up to 11,345,489 of the Private Placement Warrants.

S-1/A filing: S-1/A filing for OmniAb, Inc. registering for resale up to 36,345,645 shares of common stock and 11,345,489 warrants by selling securityholders, and up to 24,273,938 shares of common stock by the company.

S-1 filing: This S-1 filing is for the registration of 36,345,645 shares of common stock, 11,345,489 warrants, and 19,012,156 shares of common stock issuable upon exercise of warrants for resale by selling securityholders and for the issuance of shares upon exercise of options and warrants.

10-Q filing | 5.8M shares outstanding

8-K filing: APAC Class A Ordinary Shares were redeemed at approximately $10.32 per share for an aggregate of $224,048,746.95. New OmniAb will issue additional shares and warrants to the Sponsor to backstop the Redemptions and issue additional shares and warrants in a private placement. ($325.78M proceeds)

10-Q filing | 5.8M shares outstanding

10-Q filing | 5.8M shares outstanding

10-K filing | 5.3M shares outstanding

8-K filing: Avista Public Acquisition Corp. II (APAC) entered into a merger agreement with Ligand Pharmaceuticals Incorporated and OmniAb, Inc. for a Reverse Morris Trust transaction, involving the distribution of OmniAb common stock to Ligand stockholders and subsequent merger with APAC. ($30.0M proceeds)

10-Q filing | 5.8M shares outstanding

10-Q filing | 5.8M shares outstanding

8-K filing: Avista Public Acquisition Corp. II completed its initial public offering of 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000, and completed the private sale of 8,233,333 warrants to its sponsor at $1.50 per warrant, generating gross proceeds of $12,350,000. ($242.35M proceeds)

8-K filing: Avista Acquisition Corp II consummated its initial public offering of 23,000,000 units at a price of $10.00 per unit, generating gross proceeds of $230,000,000, and completed a private sale of 8,233,333 warrants to the Company's sponsor at a purchase price of $1.50 per warrant, generating gross proceeds of $12,350,000. ($242.35M proceeds)